Wang Saikun, Jiang Junjie, Zhang Changyue, Lv Mengjiao, Xu Haiyan, Meng Hongli, Guo Lirong
Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, China.
Department of Rehabilitation Medicine, the Second Hospital of Jilin University, Changchun, Jilin 130062, China.
Arch Phys Med Rehabil. 2025 Jun;106(6):949-960. doi: 10.1016/j.apmr.2024.11.005. Epub 2024 Nov 26.
To investigate the effect of virtual reality (VR)-based cardiac rehabilitation (CR) on the mental health and cardiorespiratory function of patients with cardiovascular disease (CVD).
The search strategy was conducted in 5 databases (PubMed, Scopus, Web of Science, Embase, and Cochrane Library databases) from inception to July 2024.
Randomized controlled trials comparing the effectiveness of standard CR and VR-based CR for patients with CVD were independently selected by multiple reviewers.
Data were extracted independently by 2 authors. In case of disagreement, a third author was consulted for resolution.
Thirteen studies involving 955 patients with CVD were included in the meta-analysis. The results showed that VR-based CR reduced anxiety levels (standard mean difference [SMD]=-0.28, 95% [confidence interval] CI [-0.51 to -0.05], P=.020]) and depression symptoms (SMD=-0.28, 95% CI [-0.53 to -0.02], P=.030]) in patients with CVD compared with standard CR. However, no significant difference was observed in peak oxygen consumption (SMD=0.01, 95% CI [-0.14 to 0.16], P=.920]) between standard CR and VR-based CR.
VR-based CR significantly improved anxiety and depression symptoms in patients with CVD compared with standard CR. However, there was no significant difference between standard CR and VR-based CR in improving cardiorespiratory function in patients with CVD.
探讨基于虚拟现实(VR)的心脏康复(CR)对心血管疾病(CVD)患者心理健康和心肺功能的影响。
检索策略从建库至2024年7月在5个数据库(PubMed、Scopus、科学网、Embase和Cochrane图书馆数据库)中进行。
由多位评审员独立筛选比较标准CR和基于VR的CR对CVD患者有效性的随机对照试验。
由2位作者独立提取数据。如有分歧,咨询第三位作者以解决。
13项涉及955例CVD患者的研究纳入荟萃分析。结果显示,与标准CR相比,基于VR的CR降低了CVD患者的焦虑水平(标准均数差[SMD]=-0.28,95%置信区间[CI][-0.51至-0.05],P=0.020)和抑郁症状(SMD=-0.28,95%CI[-0.53至-0.02],P=0.030)。然而,标准CR和基于VR的CR之间在峰值耗氧量方面未观察到显著差异(SMD=0.01,95%CI[-0.14至0.16],P=0.920)。
与标准CR相比,基于VR的CR显著改善了CVD患者的焦虑和抑郁症状。然而,在改善CVD患者心肺功能方面,标准CR和基于VR的CR之间没有显著差异。